233 related articles for article (PubMed ID: 27443638)
1. The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain.
Zornetta I; Azarnia Tehran D; Arrigoni G; Anniballi F; Bano L; Leka O; Zanotti G; Binz T; Montecucco C
Sci Rep; 2016 Jul; 6():30257. PubMed ID: 27443638
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel botulinum neurotoxin.
Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; Martínez-Carranza M; Dong M; Stenmark P
Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
[TBL] [Abstract][Full Text] [Related]
3. The cryo-EM structure of the BoNT/Wo-NTNH complex reveals two immunoglobulin-like domains.
Košenina S; Škerlová J; Zhang S; Dong M; Stenmark P
FEBS J; 2024 Feb; 291(4):676-689. PubMed ID: 37746829
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the catalytic domain of the Weissella oryzae botulinum-like toxin.
Košenina S; Masuyer G; Zhang S; Dong M; Stenmark P
FEBS Lett; 2019 Jun; 593(12):1403-1410. PubMed ID: 31111466
[TBL] [Abstract][Full Text] [Related]
5. Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain A neurotoxin gene cluster.
Doxey AC; Lynch MD; Müller KM; Meiering EM; McConkey BJ
BMC Evol Biol; 2008 Nov; 8():316. PubMed ID: 19014598
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin homologs in non-Clostridium species.
Mansfield MJ; Adams JB; Doxey AC
FEBS Lett; 2015 Jan; 589(3):342-8. PubMed ID: 25541486
[TBL] [Abstract][Full Text] [Related]
7. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
[TBL] [Abstract][Full Text] [Related]
8. Genomic insights into the evolution and ecology of botulinum neurotoxins.
Mansfield MJ; Doxey AC
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29684130
[TBL] [Abstract][Full Text] [Related]
9. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
10. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
Kumaran D; Eswaramoorthy S; Furey W; Navaza J; Sax M; Swaminathan S
J Mol Biol; 2009 Feb; 386(1):233-45. PubMed ID: 19118561
[TBL] [Abstract][Full Text] [Related]
11. Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.
Nuemket N; Tanaka Y; Tsukamoto K; Tsuji T; Nakamura K; Kozaki S; Yao M; Tanaka I
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May; 66(Pt 5):608-10. PubMed ID: 20445271
[TBL] [Abstract][Full Text] [Related]
12. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
Chen S; Hall C; Barbieri JT
J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
[TBL] [Abstract][Full Text] [Related]
13. Light Chain Diversity among the Botulinum Neurotoxins.
Gardner AP; Barbieri JT
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30004421
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
15. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
16. Botulinal neurotoxin C1 complex genes, clostridial neurotoxin homology and genetic transfer in Clostridium botulinum.
Hauser D; Gibert M; Marvaud JC; Eklund MW; Popoff MR
Toxicon; 1995 Apr; 33(4):515-26. PubMed ID: 7570637
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel botulinum neurotoxin gene cluster in Enterococcus.
Brunt J; Carter AT; Stringer SC; Peck MW
FEBS Lett; 2018 Feb; 592(3):310-317. PubMed ID: 29323697
[TBL] [Abstract][Full Text] [Related]
18. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.
Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
Anal Chem; 2014 Apr; 86(7):3254-62. PubMed ID: 24605815
[TBL] [Abstract][Full Text] [Related]
19. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
20. NTNH protein: more than a bodyguard for botulinum neurotoxins.
Gao L; Jin R
FEBS J; 2024 Feb; 291(4):672-675. PubMed ID: 38009421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
